The Fine Print Is Becoming the Real Risk in AI Vendor Deals
Medical Economics warns physicians not to sign AI contracts without understanding the hidden obligations and liabilities embedded in the terms. As AI vendors race into practice settings, contract language may matter as much as product features.
For many practices, the first AI risk is no longer the model itself. It is the contract.
Medical Economics’s warning about AI vendor agreements highlights an issue that often gets overlooked during procurement: legal and operational terms can quietly shift data rights, indemnification, service levels, and liability onto the buyer. In a field where clinicians already face high regulatory pressure, that can turn a promising tool into a long-term problem.
The article is timely because AI purchasing is becoming more common in ambulatory care, where smaller groups may not have deep legal or technical expertise. Vendors often lead with efficiency claims, but the real questions are buried in the paperwork: Who can use patient data for model training? What happens if the system makes an error? How easy is it to exit the contract if performance disappoints?
This is a reminder that AI adoption is not just a technology decision. It is a governance and procurement decision, and the organizations that handle it well will be those that read beyond the sales deck. In the next phase of health AI, contract literacy may be a competitive advantage.